The New Year brings hope and promises that an end to the COVID-19 pandemic is in sight. With two vaccines authorized by the FDA for emergency use, and close to 3 million healthcare workers already vaccinated, there is hope that this virus will be eradicated and life will begin to return to normal by year’s end. However, for the frontline healthcare workers still treating escalating case volumes, the physical and emotional toll is devastating. With another surge forecasted for
Read More
First Databank Clinician Addresses COVID-19 Vaccine Skepticism – Q/A
As the Biden administration ramps up its efforts to increase the access of COVID-19 vaccines to more Americans, there are a large number of Americans who are skeptical about of the COVID-19 vaccine. About 1 in 3 Americans stated they definitely or probably won’t get the COVID-19 vaccine, according to a recent poll from the Associated Press-NORC Center for Public Affairs Research. The poll reveals while 67% of Americans plan to get vaccinated or have already done so, 15% are certain they
Read More
Leveraging Technology and Data for COVID-19 Vaccine Distribution
After months of uncertainty, hope is finally on the horizon as three viable COVID-19 vaccine candidates are moving closer towards approvals for public distribution. Getting to this stage was extremely labor-intensive, but unfortunately, it’s not the end of the hardships. The coronavirus vaccine will represent the largest vaccine distribution in U.S. history, and manufacturing and distributing the vaccines will have its own fair share of difficulties for healthcare systems. In order to optimize
Read More
Amazon, AstraZeneca, Pfizer, Merck to Build $10M Digital Health Innovation Lab in Israel
What You Should Know: - Pfizer, AstraZeneca, Merck, and Teva, and Amazon Web Services (AWS) has been selected by the Israel Innovation Authority to establish an innovation lab in the fields of digital health and computational biology. - The innovation lab located in the Rehovot Science Park will
receive a government budget of $10M over the next five years and is slated to
start operations in 2021. Pfizer, AstraZeneca, Merck, and Teva, as well as the Israel Biotech Fund and tech
Read More
AMA Adds 3 Additional CPT Codes for AstraZeneca’s COVID-19 Vaccine
What You Should Know: - The American Medical Association (AMA) announced the addition of three Current Procedural Terminology (CPT) codes for AstraZeneca's COVID-19 vaccine. The American Medical Association (AMA) today announced that
the Current Procedural Terminology (CPT®) code set is
being updated by the CPT Editorial Panel to include immunization and
administration codes that are unique to the COVID-19 vaccine under development
by AstraZeneca and University of
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
Fitbit, BMS-Pfizer Alliance Partner to Address Gaps in Atrial Fibrillation Detection
- Fitbit and the BMS-Pfizer Alliance are collaborating on a multi-year effort to accelerate the detection and diagnosis of atrial fibrillation (AFib) to reduce the risk of life-threatening events, like stroke.- The companies will use their combined resources and expertise to help identify and support people at increased risk for AFib, notably those 65+. The Bristol-Myers Squibb-Pfizer Alliance and Fitbit today announced a multi-year collaboration to help drive timely diagnosis of atrial
Read More
SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals
SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will
Read More
Pfizer, Syapse Partner on Oncology Precision Medicine Using Real-World Evidence (RWE)
Syapse, a San Francisco, CA-based precision medicine company, today announced that it has entered into a strategic collaboration with Pfizer to advance cancer outcomes research using real-world evidence (RWE) toward the ultimate goal of improving patient health. This collaboration will initially focus on the molecular testing and therapy choices on precision oncology journeys in the healthcare system setting.Syapse NetworkThe Syapse Network enables health systems and their providers to learn
Read More
Pfizer, McKesson, Others Join MediLedger’s Blockchain Project Working Group
Leading life sciences and healthcare companies Pfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have joined the MediLedger Project Contracting and Chargebacks working group, a second working group running in parallel to the ongoing DSCSA working group started in 2017. MediLedger is an initiative of Chronicled, Inc., a San Francisco-based technology company, that builds blockchain-powered ecosystems and supply chain solutions.Network VisionMediLedger uses
Read More
